Comparing two pills for itching in psoriasis
Treatments studied
Part of Skin clinical trials.
This study compares two oral medications, methotrexate and apremilast, to see which works better at reducing itching in people with psoriasis. You might join to help find a more effective way to relieve itch.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a doctor's diagnosis of psoriasis.
- You have itching (pruritus) related to your psoriasis.
- You are not currently on any oral or injected psoriasis treatments (within the last 4 weeks).
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You do not have severe liver or kidney disease, active infections (like tuberculosis), cancer, or blood disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether apremilast (a pill) safely and effectively treats moderate-to-severe psoriasis. If you join, you will receive the medication and be monitored by the study team to see how well it works for you.
This study compares two oral pill treatments—methotrexate and tofacitinib—for people with chronic plaque psoriasis that is moderate to severe and hasn't responded well to creams. The goal is to see which pill works better at clearing skin.
This study looks at how well two common plaque psoriasis medicines—deucravacitinib and apremilast—work in everyday care. It may help researchers understand which option performs better in real patients outside of a traditional drug trial.
This trial tests a new cream form of apremilast, a medicine usually taken as a pill, for people with plaque psoriasis covering less than 10% of their body. The goal is to see if the cream is safe and effective in reducing psoriasis symptoms.
This study looks at a specific gene change (called TRAF3IP2) in people with psoriasis or psoriatic arthritis who are about to start methotrexate. The goal is to see if the gene affects how well the treatment works or if it causes side effects.
This trial tests whether a medicine called aprepitant can reduce itching caused by immunotherapy drugs in people with solid tumors. If you have bothersome itching that won't go away, this treatment might help.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.